Connexin-43 Alleviates Arrhythmogenic Cardiomyopathy. 01/27/26

Welcome to Cardiology Today – Recorded January 27, 2026. This episode summarizes 5 key cardiology studies on topics like inherited arrhythmias and healthcare costs. Key takeaway: Connexin-43 Alleviates Arrhythmogenic Cardiomyopathy.. Article Links: Article 1: Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. (Circulation. Heart failure) Article 2: Estimating the Potential Impact of the 2024 UK Salt Reduction Targets on Cardiovascular Health Outcomes and Health Care Costs in Adults: A Modeling Study. (Hypertension (Dallas, Tex. : 1979)) Article 3: Seated Saline Suppression Test for Lateralizing Primary Aldosteronism. (Hypertension (Dallas, Tex. : 1979)) Article 4: Phenotypic Severity of SCN5A-Related Bradycardia Is Independent of Dominant-Negative and Coupled Gating Effects. (Circulation. Arrhythmia and electrophysiology) Article 5: Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. (Circulation. Heart failure) Full episode page: https://podcast.explainheart.com/podcast/connexin-43-alleviates-arrhythmogenic-cardiomyopathy-01-27-26/ Featured Articles Article 1: Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. Journal: Circulation. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41582809 Summary: This study found that restoration of Connexin-43 alleviated desmosomal arrhythmogenic cardiomyopathy. Arrhythmogenic cardiomyopathy is a fatal genetic heart disease characterized by impaired cell-cell adhesion, ventricular arrhythmias, and progressive heart failure. This finding demonstrates a potential mutation-agnostic therapeutic intervention for this severe and genetically broad patient population. This approach addresses dysregulated pathways across various desmosomal mutations. Article 2: Estimating the Potential Impact of the 2024 UK Salt Reduction Targets on Cardiovascular Health Outcomes and Health Care Costs in Adults: A Modeling Study. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41582820 Summary: This modeling study projected the potential impact of the 2024 United Kingdom salt reduction targets on cardiovascular health outcomes and health care costs in adults. The analysis found that meeting these targets could significantly improve population cardiovascular health. The reductions in sodium intake were projected to also lead to substantial savings in healthcare expenditures for United Kingdom adults. The study highlights the positive public health implications of such voluntary salt reduction programs. Article 3: Seated Saline Suppression Test for Lateralizing Primary Aldosteronism. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41582811 Summary: This blinded clinical trial identified the diagnostic accuracy of the Seated Saline Suppression Test for lateralizing primary aldosteronism. The study found the test accurately identified lateralization, defined by an aldosterone-to-cortisol ratio of 3:1 or greater during adrenal vein sampling. This finding provides crucial clarity on confirmatory testing for primary aldosteronism, addressing previous uncertainty regarding its benefit in identifying lateralizing disease. The Seated Saline Suppression Test offered a precise approach for patients presenting with high-risk features. Article 4: Phenotypic Severity of SCN5A-Related Bradycardia Is Independent of Dominant-Negative and Coupled Gating Effects. Journal: Circulation. Arrhythmia and electrophysiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41582807 Summary: This study found that the phenotypic severity of sodium voltage gated channel alpha subunit 5 A-related bradycardia is independent of dominant-negative and coupled gating effects. Pathogenic SCN5A variants are associated with inherited arrhythmias such as long Q. T. syndrome, Brugada syndrome, and sick sinus syndrome. Results showed a reduction of sodium current in wild-type NaV1.5 can be caused by dimerization with loss-of-function mutated NaV1.5 through dominant-negative effects. This clarifies the mechanisms underlying SCN5A-related bradycardia, demonstrating its severity is not dictated by these specific molecular interactions. Article 5: Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. Journal: Circulation. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41582809 Summary: This study found that restoration of Connexin-43 alleviated desmosomal arrhythmogenic cardiomyopathy. Arrhythmogenic cardiomyopathy is a fatal genetic heart disease characterized by impaired cell-cell adhesion, ventricular arrhythmias, and progressive heart failure. This finding demonstrates a potential mutation-agnostic therapeutic intervention for this severe and genetically broad patient population. This approach addresses dysregulated pathways across various desmosomal mutations. Transcript Today’s date is January 27, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. This study found that restoration of Connexin-43 alleviated desmosomal arrhythmogenic cardiomyopathy. Arrhythmogenic cardiomyopathy is a fatal genetic heart disease characterized by impaired cell-cell adhesion, ventricular arrhythmias, and progressive heart failure. This finding demonstrates a potential mutation-agnostic therapeutic intervention for this severe and genetically broad patient population. This approach addresses dysregulated pathways across various desmosomal mutations. Article number two. Estimating the Potential Impact of the 2024 UK Salt Reduction Targets on Cardiovascular Health Outcomes and Health Care Costs in Adults: A Modeling Study. This modeling study projected the potential impact of the 2024 United Kingdom salt reduction targets on cardiovascular health outcomes and health care costs in adults. The analysis found that meeting these targets could significantly improve population cardiovascular health. The reductions in sodium intake were projected to also lead to substantial savings in healthcare expenditures for United Kingdom adults. The study highlights the positive public health implications of such voluntary salt reduction programs. Article number three. Seated Saline Suppression Test for Lateralizing Primary Aldosteronism. This blinded clinical trial identified the diagnostic accuracy of the Seated Saline Suppression Test for lateralizing primary aldosteronism. The study found the test accurately identified lateralization, defined by an aldosterone-to-cortisol ratio of 3:1 or greater during adrenal vein sampling. This finding provides crucial clarity on confirmatory testing for primary aldosteronism, addressing previous uncertainty regarding its benefit in identifying lateralizing disease. The Seated Saline Suppression Test offered a precise approach for patients presenting with high-risk features. Article number four. Phenotypic Severity of SCN5A-Related Bradycardia Is Independent of Dominant-Negative and Coupled Gating Effects. This study found that the phenotypic severity of sodium voltage gated channel alpha subunit 5 A-related bradycardia is independent of dominant-negative and coupled gating effects. Pathogenic SCN5A variants are associated with inherited arrhythmias such as long Q. T. syndrome, Brugada syndrome, and sick sinus syndrome. Results showed a reduction of sodium current in wild-type NaV1.5 can be caused by dimerization with loss-of-function mutated NaV1.5 through dominant-negative effects. This clarifies the mechanisms underlying SCN5A-related bradycardia, demonstrating its severity is not dictated by these specific molecular interactions. Article number five. Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. This study found that restoration of Connexin-43 alleviated desmosomal arrhythmogenic cardiomyopathy. Arrhythmogenic cardiomyopathy is a fatal genetic heart disease characterized by impaired cell-cell adhesion, ventricular arrhythmias, and progressive heart failure. This finding demonstrates a potential mutation-agnostic therapeutic intervention for this severe and genetically broad patient population. This approach addresses dysregulated pathways across various desmosomal mutations. Thank you for listening. Don’t forget to subscribe. Keywords inherited arrhythmias, healthcare costs, salt reduction, adrenal vein sampling, cardiac sodium channel, lateralization, dominant-negative effects, Arrhythmogenic Cardiomyopathy, sodium intake, bradycardia, ventricular arrhythmias, cardiovascular health, Connexin-43, public health, desmosomal genes, diagnostic accuracy, Seated Saline Suppression Test, primary aldosteronism, heart failure, SCN5A variants. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Connexin-43 Alleviates Arrhythmogenic Cardiomyopathy. 01/27/26 first appeared on Cardiology Today.